Aref Al-Kali
机构：Mayo Clinic, Mayo Clinic in Arizona
发表论文 10 篇 · 总被引 6 次 · h-index 1
代表论文
- CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients (2026 · Blood Cancer Journal · 被引 2)
- Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database (2026 · Blood Cancer Journal · 被引 1)
- Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents (2026 · American Journal of Hematology · 被引 1)
- Outcomes of hemophagocytic lymphohistiocytosis in acute myeloid leukemia: the 3-site Mayo Clinic experience (2026 · Blood Neoplasia · 被引 1)
- Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma (2026 · Blood Cancer Journal)
- Prognostic significance of CUX1 genomic deletion in myelodysplastic neoplasms (2026 · Annals of Hematology)